Download Intraperitoneal Cancer Therapy (Current Clinical Oncology) by C. William Helm, Robert Edwards PDF

By C. William Helm, Robert Edwards

Intraperitoneal melanoma remedy investigates intraperitoneal chemotherapy in numerous advanced and engaging methods. the amount information significant scientific trails thus far, together with immunotherapy, hyperthermic remedy of colo-rectal and ovarian cancers. Authors additionally research local methods to remedy, systemic remedy, and using carboplatin and paclitaxel because the average therapy for ladies with levels III and IV ovarian melanoma. different chapters additionally examine concepts and strategies in remedy, in addition to the longer term path of either normothermic and hyperthermic intraperitoneal chemotherapy.

Show description

Read or Download Intraperitoneal Cancer Therapy (Current Clinical Oncology) PDF

Similar obstetrics & gynecology books

Chesley's Hypertensive Disorders in Pregnancy, 3rd Edition

Hypertensive issues stay one the main reasons of maternal and fetal morbidity and demise. it's also a number one reason behind preterm beginning referred to now to be a chance consider distant heart problems. regardless of this the hypertensive problems stay marginally studied and administration is usually debatable.

Tumors of the Fetus and Infant: An Atlas

Over the last 20 years, the outstanding advances in imaging innovations, comparable to ultrasound and quickly or ultra-fast MRI, have ended in the prognosis of a growing number of tumors on the prenatal level. This revised, abundantly illustrated moment variation of Tumors of the Fetus and little one: An Atlas offers an up to date account of the scientific and pathological gains of neoplastic disorder and tumor-like stipulations within the fetus, neonate, and baby and discusses significant tumor reports and instances from in the course of the global.

Spontaneous Abortion: Diagnosis and Treatment

16 British experts pool their wide wisdom of spontaneous abortion in a single resource. Their dialogue is at once appropriate to scientific events and is helping establish parts of discussion and substitute equipment.

Additional info for Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Example text

PHASE II TRIAL EXPERIENCE WITH IP CISPLATIN IN OVARIAN CANCER Predictably, based on its central role in the management of ovarian cancer, much of the initial phase II trial effort (both single-agent and combination chemotherapy regimens) in the malignancy focused on cisplatin (30–37). Further, with few exceptions, the early phase II IP trials in ovarian cancer were directed toward treating women with this strategy as a “second-line” treatment approach. Exploration of the activity of IP cisplatin in this particular clinical setting permitted a most interesting, and rather unique, analysis.

The study by Markman (6) is particularly confounding because women allocated an IP component to their treatment also received an additional very high “priming” dose of IV carboplatin. Data on the risk of thrombocytopenia, leukopenia, renal toxicity, gastrointestinal toxicity, and neurological toxicity are heterogeneous and cannot be combined legitimately. However, data on fever, pain, infection, fatigue, and ototoxicity passed the test of homogeneity. 5 2 Favors IV Fig. 2. Forrest plot showing time from randomization to death (above) and time from randomization to recurrent disease (below).

Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 1982;42:4265–4269. 7. Alberts DS, Surwit EA, Peng YM, et al. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration. Cancer Res 1988;48: 5874–5877. 8. Howell SB, Pfeifle CL, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982;97:845–851. 9. Lopez JA, Krikorian JG, Reich SD, et al.

Download PDF sample

Rated 4.37 of 5 – based on 22 votes